Exon skipping compositions for treating muscular dystrophy Grant US-11932851-B2 United States of America 19 Mar 2024
Extracellular mRNA markers of muscular dystrophies in human urine Grant US-11866783-B2 United States of America 09 Jan 2024
Adeno-associated virus vector delivery of micro-dystrophin to treat muscular dystrophy Grant US-11723986-B2 United States of America 15 Aug 2023
Adeno-associated virus vector delivery of muscle specific micro-dystrophin to treat… Grant US-11534501-B2 United States of America 27 Dec 2022
Antisense molecules and methods for treating pathologies Grant US-11447776-B2 United States of America 20 Sep 2022
Adeno-associated virus vector delivery of microRNA-29 and micro-dystrophin to treat… Grant US-11406717-B2 United States of America 09 Aug 2022
Adeno-associated virus vector delivery of microrna-29 to treat muscular dystrophy Grant US-11298429-B2 United States of America 12 Apr 2022
Methods of administering deflazacort therapy Grant US-11083737-B1 United States of America 10 Aug 2021
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-10995337-B2 United States of America 04 May 2021
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-10968450-B2 United States of America 06 Apr 2021
Exon skipping compositions for treating muscular dystrophy Grant US-10907154-B2 United States of America 02 Feb 2021
Antisense molecules and methods for treating pathologies Grant US-10781450-B2 United States of America 22 Sep 2020
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-10781451-B2 United States of America 22 Sep 2020
IMPROVED DOSAGES OF ETEPLIRSEN FOR TREATING DUCHENNE MUSCULAR DYSTROPHY Application EP-3662912-A1 European Patent Office 10 Jun 2020
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-RE47769-E1 United States of America 17 Dec 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-RE47751-E1 United States of America 03 Dec 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-RE47691-E1 United States of America 05 Nov 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-10421966-B2 United States of America 24 Sep 2019
Compositions for treating muscular dystrophy Grant US-10364431-B2 United States of America 30 Jul 2019
Compositions for treating muscular dystrophy Grant US-10337003-B2 United States of America 02 Jul 2019
Antisense molecules and methods for treating pathologies Grant US-10287586-B2 United States of America 14 May 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-10266827-B2 United States of America 23 Apr 2019
COMBINATION THERAPIES FOR TREATING MUSCULAR DYSTROPHY Application WO-2019067979-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2019
COMBINATION THERAPIES FOR TREATING MUSCULAR DYSTROPHY Application WO-2019067975-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2019
COMBINATION THERAPIES FOR TREATING MUSCULAR DYSTROPHY Application WO-2019067981-A1 World Intellectual Property Organisation (WIPO) 04 Apr 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-10227590-B2 United States of America 12 Mar 2019
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-9994851-B2 United States of America 12 Jun 2018
Antisense molecules and methods for treating pathologies Grant US-9758783-B2 United States of America 12 Sep 2017
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-9605262-B2 United States of America 28 Mar 2017
Compositions for treating muscular dystrophy Grant US-9506058-B2 United States of America 29 Nov 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-9447415-B2 United States of America 20 Sep 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-9441229-B2 United States of America 13 Sep 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-9422555-B2 United States of America 23 Aug 2016
Antisense oligonucleotides for inducing exon skipping and methods of use thereof Grant US-9249416-B2 United States of America 02 Feb 2016
Antisense molecules and methods for treating pathologies Grant US-9228187-B2 United States of America 05 Jan 2016
Exon skipping compositions for treating muscular dystrophy Grant US-9217148-B2 United States of America 22 Dec 2015
IMPROVED COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY Application WO-2014144978-A2 World Intellectual Property Organisation (WIPO) 18 Sep 2014